Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 57.84% | 54.87% | 52.06% | 34.26% | 18.15% |
| Total Depreciation and Amortization | -4.35% | -5.00% | -6.73% | -10.68% | -13.22% |
| Total Amortization of Deferred Charges | -77.72% | -60.05% | -43.11% | -24.06% | -20.10% |
| Total Other Non-Cash Items | -61.11% | -59.10% | -49.79% | 4.86% | 75.13% |
| Change in Net Operating Assets | 82.92% | 83.30% | -43.36% | -176.59% | -3,015.92% |
| Cash from Operations | 62.27% | 60.63% | 45.24% | 31.60% | 23.57% |
| Capital Expenditure | 10.00% | -433.33% | -75.00% | 66.67% | 84.62% |
| Sale of Property, Plant, and Equipment | -100.00% | -87.69% | -88.89% | -48.21% | -24.74% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.41% | 60.54% | 393.15% | 2,142.66% | -53.54% |
| Cash from Investing | 47.17% | 58.82% | 379.74% | 1,971.12% | -53.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -59.88% | -82.71% | -105.56% | -157.97% | -9.07% |
| Issuance of Common Stock | -84.26% | -84.56% | -84.57% | -58.11% | 4,945.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 44.51% | 44.51% | 61.60% | 61.60% | 30.80% |
| Other Financing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | -194.96% | -208.64% | -227.15% | -335.15% | 242.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.62% | 22.53% | 55.53% | 48.05% | 69.71% |